Japan's Astellas to buy US-based Audentes for $3b in gene therapy push

Japan's Astellas to buy US-based Audentes for $3b in gene therapy push

Photo: Pixabay

Japan’s Astellas Pharma Inc has agreed to buy Audentes Therapeutics Inc for about $3 billion in cash as it seeks to make genetic medicines a key area of growth.